Related Experiment Videos

Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA

Voyce1, Heller, Weiner

  • 1Division of Cardiology, Interventional Cardiology and Thrombosis Research Center, Clinical Trials Section, University of Massachusetts Medical School, Worcester, MA.

Insights

Activated coagulation time (ACT)-guided heparin dosing significantly reduces acute and delayed vessel closure during percutaneous coronary interventions (PCI). This strategy proves effective even for high-risk patients undergoing PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Intracoronary thrombosis is a key factor in acute complications during percutaneous coronary interventions (PCI).
  • Activated Coagulation Time (ACT) is a standard bedside test for monitoring heparin's anticoagulant effect during PCI.
  • Empirical heparin dosing strategies may not adequately address patient-specific risks.

Purpose of the Study:

  • To evaluate if ACT-adjusted heparin dosing reduces procedure-related complications in elective percutaneous transluminal coronary angioplasty (PTCA).
  • To compare complication rates between empirical heparin dosing and ACT-guided heparin administration.

Main Methods:

  • A retrospective study of 1200 patients undergoing elective PTCA between January 1988 and February 1992.
  • Patients were divided into two groups: empirical heparin (Group 1) and ACT-guided heparin (Group 2).
  • Clinical, angiographic, and procedural data were analyzed to compare complication rates.

Main Results:

  • Group 2 patients had a higher-risk profile (older, worse LV function, prior MI) than Group 1.
  • ACT-guided heparin therapy (Group 2) resulted in a ~50% reduction in abrupt vessel closure (6.9% vs. 3.5%).
  • Delayed vessel closure was significantly reduced by over 60% in Group 2 (3.2% vs. 1.0%).

Conclusions:

  • ACT-guided heparin therapy during PCI effectively decreases both acute and delayed vessel closure.
  • This approach improves outcomes even in patients with clinical and angiographic characteristics predicting higher complication rates.
  • ACT monitoring offers a superior strategy for heparin management in PCI compared to empirical dosing.

Related Concept Videos